0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-20D18665
Home | Market Reports | Science| Biological Sciences
Global Peptide PNA Peptide nucleic acid Conjugate Market Research Report 2024
BUY CHAPTERS

Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Research Report 2024

Code: QYRE-Auto-20D18665
Report
November 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Peptide-PNA (Peptide nucleic acid) Conjugate Market

Peptide nucleic acids (PNAs) are artificially synthesized polymers which mimic DNA or RNA.PNA oligonucleotides can be conjugated to peptides to provide additional functionality. The peptide-PNA conjugate (KFFKFFKFFK-{CTCATACTCT}-NH2) is an example. It represents a cutting-edge approach to combat multi-drug resistant bacteria. In addition, the combination of CPP and PNA also has good prospects in the biomedical field.
The global Peptide-PNA (Peptide nucleic acid) Conjugate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Peptide-PNA (Peptide nucleic acid) Conjugate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Peptide-PNA (Peptide nucleic acid) Conjugate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Peptide-PNA (Peptide nucleic acid) Conjugate include HLB panagene, LifeTein, Smartox Biotechnology (SB-PEPTIDE), LGC Biosearch Technologies, SBS Genetech, Creative Biogene, Creative Peptides, Medtide Inc, PNA BIO INC, Bio-Synthesis Inc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peptide-PNA (Peptide nucleic acid) Conjugate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide-PNA (Peptide nucleic acid) Conjugate.
The Peptide-PNA (Peptide nucleic acid) Conjugate market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peptide-PNA (Peptide nucleic acid) Conjugate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide-PNA (Peptide nucleic acid) Conjugate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Peptide-PNA (Peptide nucleic acid) Conjugate Market Report

Report Metric Details
Report Name Peptide-PNA (Peptide nucleic acid) Conjugate Market
by Type
  • Short Peptide-conjugation
  • Long Peptide-conjugation
by Application
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company HLB panagene, LifeTein, Smartox Biotechnology (SB-PEPTIDE), LGC Biosearch Technologies, SBS Genetech, Creative Biogene, Creative Peptides, Medtide Inc, PNA BIO INC, Bio-Synthesis Inc, PANAGENE, QiYuebio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Peptide-PNA (Peptide nucleic acid) Conjugate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Peptide-PNA (Peptide nucleic acid) Conjugate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Peptide-PNA (Peptide nucleic acid) Conjugate Market report?

Ans: The main players in the Peptide-PNA (Peptide nucleic acid) Conjugate Market are HLB panagene, LifeTein, Smartox Biotechnology (SB-PEPTIDE), LGC Biosearch Technologies, SBS Genetech, Creative Biogene, Creative Peptides, Medtide Inc, PNA BIO INC, Bio-Synthesis Inc, PANAGENE, QiYuebio

What are the Application segmentation covered in the Peptide-PNA (Peptide nucleic acid) Conjugate Market report?

Ans: The Applications covered in the Peptide-PNA (Peptide nucleic acid) Conjugate Market report are Molecular Probes, Gene Editing, Drug delivey, Other

What are the Type segmentation covered in the Peptide-PNA (Peptide nucleic acid) Conjugate Market report?

Ans: The Types covered in the Peptide-PNA (Peptide nucleic acid) Conjugate Market report are Short Peptide-conjugation, Long Peptide-conjugation

Recommended Reports

Peptide Therapeutics

Nucleic Acid Markets

Conjugate Technologies

1 Peptide-PNA (Peptide nucleic acid) Conjugate Market Overview
1.1 Product Definition
1.2 Peptide-PNA (Peptide nucleic acid) Conjugate by Type
1.2.1 Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Value Comparison by Type (2024-2030)
1.2.2 Short Peptide-conjugation
1.2.3 Long Peptide-conjugation
1.3 Peptide-PNA (Peptide nucleic acid) Conjugate by Application
1.3.1 Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Value by Application (2024-2030)
1.3.2 Molecular Probes
1.3.3 Gene Editing
1.3.4 Drug delivey
1.3.5 Other
1.4 Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Size Estimates and Forecasts
1.4.1 Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue 2019-2030
1.4.2 Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales 2019-2030
1.4.3 Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Peptide-PNA (Peptide nucleic acid) Conjugate Market Competition by Manufacturers
2.1 Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales Market Share by Manufacturers (2019-2024)
2.2 Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Peptide-PNA (Peptide nucleic acid) Conjugate Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Peptide-PNA (Peptide nucleic acid) Conjugate, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Peptide-PNA (Peptide nucleic acid) Conjugate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peptide-PNA (Peptide nucleic acid) Conjugate, Product Type & Application
2.7 Global Key Manufacturers of Peptide-PNA (Peptide nucleic acid) Conjugate, Date of Enter into This Industry
2.8 Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Competitive Situation and Trends
2.8.1 Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Peptide-PNA (Peptide nucleic acid) Conjugate Players Market Share by Revenue
2.8.3 Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Scenario by Region
3.1 Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Region: 2019-2030
3.2.1 Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Region: 2019-2024
3.2.2 Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Region: 2025-2030
3.3 Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Region: 2019-2030
3.3.1 Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Region: 2019-2024
3.3.2 Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Region: 2025-2030
3.4 North America Peptide-PNA (Peptide nucleic acid) Conjugate Market Facts & Figures by Country
3.4.1 North America Peptide-PNA (Peptide nucleic acid) Conjugate Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Country (2019-2030)
3.4.3 North America Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Peptide-PNA (Peptide nucleic acid) Conjugate Market Facts & Figures by Country
3.5.1 Europe Peptide-PNA (Peptide nucleic acid) Conjugate Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Country (2019-2030)
3.5.3 Europe Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peptide-PNA (Peptide nucleic acid) Conjugate Market Facts & Figures by Region
3.6.1 Asia Pacific Peptide-PNA (Peptide nucleic acid) Conjugate Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Region (2019-2030)
3.6.3 Asia Pacific Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Peptide-PNA (Peptide nucleic acid) Conjugate Market Facts & Figures by Country
3.7.1 Latin America Peptide-PNA (Peptide nucleic acid) Conjugate Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Country (2019-2030)
3.7.3 Latin America Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Peptide-PNA (Peptide nucleic acid) Conjugate Market Facts & Figures by Country
3.8.1 Middle East and Africa Peptide-PNA (Peptide nucleic acid) Conjugate Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Country (2019-2030)
3.8.3 Middle East and Africa Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Type (2019-2030)
4.1.1 Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Type (2019-2024)
4.1.2 Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Type (2025-2030)
4.1.3 Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales Market Share by Type (2019-2030)
4.2 Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Type (2019-2030)
4.2.1 Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Type (2019-2024)
4.2.2 Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Type (2025-2030)
4.2.3 Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Market Share by Type (2019-2030)
4.3 Global Peptide-PNA (Peptide nucleic acid) Conjugate Price by Type (2019-2030)
5 Segment by Application
5.1 Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Application (2019-2030)
5.1.1 Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Application (2019-2024)
5.1.2 Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Application (2025-2030)
5.1.3 Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales Market Share by Application (2019-2030)
5.2 Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Application (2019-2030)
5.2.1 Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Application (2019-2024)
5.2.2 Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Application (2025-2030)
5.2.3 Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Market Share by Application (2019-2030)
5.3 Global Peptide-PNA (Peptide nucleic acid) Conjugate Price by Application (2019-2030)
6 Key Companies Profiled
6.1 HLB panagene
6.1.1 HLB panagene Company Information
6.1.2 HLB panagene Description and Business Overview
6.1.3 HLB panagene Peptide-PNA (Peptide nucleic acid) Conjugate Sales, Revenue and Gross Margin (2019-2024)
6.1.4 HLB panagene Peptide-PNA (Peptide nucleic acid) Conjugate Product Portfolio
6.1.5 HLB panagene Recent Developments/Updates
6.2 LifeTein
6.2.1 LifeTein Company Information
6.2.2 LifeTein Description and Business Overview
6.2.3 LifeTein Peptide-PNA (Peptide nucleic acid) Conjugate Sales, Revenue and Gross Margin (2019-2024)
6.2.4 LifeTein Peptide-PNA (Peptide nucleic acid) Conjugate Product Portfolio
6.2.5 LifeTein Recent Developments/Updates
6.3 Smartox Biotechnology (SB-PEPTIDE)
6.3.1 Smartox Biotechnology (SB-PEPTIDE) Company Information
6.3.2 Smartox Biotechnology (SB-PEPTIDE) Description and Business Overview
6.3.3 Smartox Biotechnology (SB-PEPTIDE) Peptide-PNA (Peptide nucleic acid) Conjugate Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Smartox Biotechnology (SB-PEPTIDE) Peptide-PNA (Peptide nucleic acid) Conjugate Product Portfolio
6.3.5 Smartox Biotechnology (SB-PEPTIDE) Recent Developments/Updates
6.4 LGC Biosearch Technologies
6.4.1 LGC Biosearch Technologies Company Information
6.4.2 LGC Biosearch Technologies Description and Business Overview
6.4.3 LGC Biosearch Technologies Peptide-PNA (Peptide nucleic acid) Conjugate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LGC Biosearch Technologies Peptide-PNA (Peptide nucleic acid) Conjugate Product Portfolio
6.4.5 LGC Biosearch Technologies Recent Developments/Updates
6.5 SBS Genetech
6.5.1 SBS Genetech Company Information
6.5.2 SBS Genetech Description and Business Overview
6.5.3 SBS Genetech Peptide-PNA (Peptide nucleic acid) Conjugate Sales, Revenue and Gross Margin (2019-2024)
6.5.4 SBS Genetech Peptide-PNA (Peptide nucleic acid) Conjugate Product Portfolio
6.5.5 SBS Genetech Recent Developments/Updates
6.6 Creative Biogene
6.6.1 Creative Biogene Company Information
6.6.2 Creative Biogene Description and Business Overview
6.6.3 Creative Biogene Peptide-PNA (Peptide nucleic acid) Conjugate Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Creative Biogene Peptide-PNA (Peptide nucleic acid) Conjugate Product Portfolio
6.6.5 Creative Biogene Recent Developments/Updates
6.7 Creative Peptides
6.7.1 Creative Peptides Company Information
6.7.2 Creative Peptides Description and Business Overview
6.7.3 Creative Peptides Peptide-PNA (Peptide nucleic acid) Conjugate Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Creative Peptides Peptide-PNA (Peptide nucleic acid) Conjugate Product Portfolio
6.7.5 Creative Peptides Recent Developments/Updates
6.8 Medtide Inc
6.8.1 Medtide Inc Company Information
6.8.2 Medtide Inc Description and Business Overview
6.8.3 Medtide Inc Peptide-PNA (Peptide nucleic acid) Conjugate Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Medtide Inc Peptide-PNA (Peptide nucleic acid) Conjugate Product Portfolio
6.8.5 Medtide Inc Recent Developments/Updates
6.9 PNA BIO INC
6.9.1 PNA BIO INC Company Information
6.9.2 PNA BIO INC Description and Business Overview
6.9.3 PNA BIO INC Peptide-PNA (Peptide nucleic acid) Conjugate Sales, Revenue and Gross Margin (2019-2024)
6.9.4 PNA BIO INC Peptide-PNA (Peptide nucleic acid) Conjugate Product Portfolio
6.9.5 PNA BIO INC Recent Developments/Updates
6.10 Bio-Synthesis Inc
6.10.1 Bio-Synthesis Inc Company Information
6.10.2 Bio-Synthesis Inc Description and Business Overview
6.10.3 Bio-Synthesis Inc Peptide-PNA (Peptide nucleic acid) Conjugate Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bio-Synthesis Inc Peptide-PNA (Peptide nucleic acid) Conjugate Product Portfolio
6.10.5 Bio-Synthesis Inc Recent Developments/Updates
6.11 PANAGENE
6.11.1 PANAGENE Company Information
6.11.2 PANAGENE Description and Business Overview
6.11.3 PANAGENE Peptide-PNA (Peptide nucleic acid) Conjugate Sales, Revenue and Gross Margin (2019-2024)
6.11.4 PANAGENE Peptide-PNA (Peptide nucleic acid) Conjugate Product Portfolio
6.11.5 PANAGENE Recent Developments/Updates
6.12 QiYuebio
6.12.1 QiYuebio Company Information
6.12.2 QiYuebio Description and Business Overview
6.12.3 QiYuebio Peptide-PNA (Peptide nucleic acid) Conjugate Sales, Revenue and Gross Margin (2019-2024)
6.12.4 QiYuebio Peptide-PNA (Peptide nucleic acid) Conjugate Product Portfolio
6.12.5 QiYuebio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peptide-PNA (Peptide nucleic acid) Conjugate Industry Chain Analysis
7.2 Peptide-PNA (Peptide nucleic acid) Conjugate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peptide-PNA (Peptide nucleic acid) Conjugate Production Mode & Process
7.4 Peptide-PNA (Peptide nucleic acid) Conjugate Sales and Marketing
7.4.1 Peptide-PNA (Peptide nucleic acid) Conjugate Sales Channels
7.4.2 Peptide-PNA (Peptide nucleic acid) Conjugate Distributors
7.5 Peptide-PNA (Peptide nucleic acid) Conjugate Customers
8 Peptide-PNA (Peptide nucleic acid) Conjugate Market Dynamics
8.1 Peptide-PNA (Peptide nucleic acid) Conjugate Industry Trends
8.2 Peptide-PNA (Peptide nucleic acid) Conjugate Market Drivers
8.3 Peptide-PNA (Peptide nucleic acid) Conjugate Market Challenges
8.4 Peptide-PNA (Peptide nucleic acid) Conjugate Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales (Kg) of Key Manufacturers (2019-2024)
 Table 5. Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Peptide-PNA (Peptide nucleic acid) Conjugate Average Price (US$/g) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Peptide-PNA (Peptide nucleic acid) Conjugate, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Peptide-PNA (Peptide nucleic acid) Conjugate, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Peptide-PNA (Peptide nucleic acid) Conjugate, Product Type & Application
 Table 12. Global Key Manufacturers of Peptide-PNA (Peptide nucleic acid) Conjugate, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Peptide-PNA (Peptide nucleic acid) Conjugate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-PNA (Peptide nucleic acid) Conjugate as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Region (2019-2024) & (Kg)
 Table 18. Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales Market Share by Region (2019-2024)
 Table 19. Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Region (2025-2030) & (Kg)
 Table 20. Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales Market Share by Region (2025-2030)
 Table 21. Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Market Share by Region (2019-2024)
 Table 23. Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Market Share by Region (2025-2030)
 Table 25. North America Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Country (2019-2024) & (Kg)
 Table 27. North America Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Country (2025-2030) & (Kg)
 Table 28. North America Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Country (2019-2024) & (Kg)
 Table 32. Europe Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Country (2025-2030) & (Kg)
 Table 33. Europe Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Region (2019-2024) & (Kg)
 Table 37. Asia Pacific Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Region (2025-2030) & (Kg)
 Table 38. Asia Pacific Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Country (2019-2024) & (Kg)
 Table 42. Latin America Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Country (2025-2030) & (Kg)
 Table 43. Latin America Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Country (2019-2024) & (Kg)
 Table 47. Middle East and Africa Peptide-PNA (Peptide nucleic acid) Conjugate Sales by Country (2025-2030) & (Kg)
 Table 48. Middle East and Africa Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Peptide-PNA (Peptide nucleic acid) Conjugate Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales (Kg) by Type (2019-2024)
 Table 51. Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales (Kg) by Type (2025-2030)
 Table 52. Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales Market Share by Type (2019-2024)
 Table 53. Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales Market Share by Type (2025-2030)
 Table 54. Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Market Share by Type (2019-2024)
 Table 57. Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Market Share by Type (2025-2030)
 Table 58. Global Peptide-PNA (Peptide nucleic acid) Conjugate Price (US$/g) by Type (2019-2024)
 Table 59. Global Peptide-PNA (Peptide nucleic acid) Conjugate Price (US$/g) by Type (2025-2030)
 Table 60. Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales (Kg) by Application (2019-2024)
 Table 61. Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales (Kg) by Application (2025-2030)
 Table 62. Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales Market Share by Application (2019-2024)
 Table 63. Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales Market Share by Application (2025-2030)
 Table 64. Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Market Share by Application (2019-2024)
 Table 67. Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Market Share by Application (2025-2030)
 Table 68. Global Peptide-PNA (Peptide nucleic acid) Conjugate Price (US$/g) by Application (2019-2024)
 Table 69. Global Peptide-PNA (Peptide nucleic acid) Conjugate Price (US$/g) by Application (2025-2030)
 Table 70. HLB panagene Company Information
 Table 71. HLB panagene Description and Business Overview
 Table 72. HLB panagene Peptide-PNA (Peptide nucleic acid) Conjugate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 73. HLB panagene Peptide-PNA (Peptide nucleic acid) Conjugate Product
 Table 74. HLB panagene Recent Developments/Updates
 Table 75. LifeTein Company Information
 Table 76. LifeTein Description and Business Overview
 Table 77. LifeTein Peptide-PNA (Peptide nucleic acid) Conjugate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 78. LifeTein Peptide-PNA (Peptide nucleic acid) Conjugate Product
 Table 79. LifeTein Recent Developments/Updates
 Table 80. Smartox Biotechnology (SB-PEPTIDE) Company Information
 Table 81. Smartox Biotechnology (SB-PEPTIDE) Description and Business Overview
 Table 82. Smartox Biotechnology (SB-PEPTIDE) Peptide-PNA (Peptide nucleic acid) Conjugate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 83. Smartox Biotechnology (SB-PEPTIDE) Peptide-PNA (Peptide nucleic acid) Conjugate Product
 Table 84. Smartox Biotechnology (SB-PEPTIDE) Recent Developments/Updates
 Table 85. LGC Biosearch Technologies Company Information
 Table 86. LGC Biosearch Technologies Description and Business Overview
 Table 87. LGC Biosearch Technologies Peptide-PNA (Peptide nucleic acid) Conjugate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 88. LGC Biosearch Technologies Peptide-PNA (Peptide nucleic acid) Conjugate Product
 Table 89. LGC Biosearch Technologies Recent Developments/Updates
 Table 90. SBS Genetech Company Information
 Table 91. SBS Genetech Description and Business Overview
 Table 92. SBS Genetech Peptide-PNA (Peptide nucleic acid) Conjugate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 93. SBS Genetech Peptide-PNA (Peptide nucleic acid) Conjugate Product
 Table 94. SBS Genetech Recent Developments/Updates
 Table 95. Creative Biogene Company Information
 Table 96. Creative Biogene Description and Business Overview
 Table 97. Creative Biogene Peptide-PNA (Peptide nucleic acid) Conjugate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 98. Creative Biogene Peptide-PNA (Peptide nucleic acid) Conjugate Product
 Table 99. Creative Biogene Recent Developments/Updates
 Table 100. Creative Peptides Company Information
 Table 101. Creative Peptides Description and Business Overview
 Table 102. Creative Peptides Peptide-PNA (Peptide nucleic acid) Conjugate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 103. Creative Peptides Peptide-PNA (Peptide nucleic acid) Conjugate Product
 Table 104. Creative Peptides Recent Developments/Updates
 Table 105. Medtide Inc Company Information
 Table 106. Medtide Inc Description and Business Overview
 Table 107. Medtide Inc Peptide-PNA (Peptide nucleic acid) Conjugate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 108. Medtide Inc Peptide-PNA (Peptide nucleic acid) Conjugate Product
 Table 109. Medtide Inc Recent Developments/Updates
 Table 110. PNA BIO INC Company Information
 Table 111. PNA BIO INC Description and Business Overview
 Table 112. PNA BIO INC Peptide-PNA (Peptide nucleic acid) Conjugate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 113. PNA BIO INC Peptide-PNA (Peptide nucleic acid) Conjugate Product
 Table 114. PNA BIO INC Recent Developments/Updates
 Table 115. Bio-Synthesis Inc Company Information
 Table 116. Bio-Synthesis Inc Description and Business Overview
 Table 117. Bio-Synthesis Inc Peptide-PNA (Peptide nucleic acid) Conjugate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 118. Bio-Synthesis Inc Peptide-PNA (Peptide nucleic acid) Conjugate Product
 Table 119. Bio-Synthesis Inc Recent Developments/Updates
 Table 120. PANAGENE Company Information
 Table 121. PANAGENE Description and Business Overview
 Table 122. PANAGENE Peptide-PNA (Peptide nucleic acid) Conjugate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 123. PANAGENE Peptide-PNA (Peptide nucleic acid) Conjugate Product
 Table 124. PANAGENE Recent Developments/Updates
 Table 125. QiYuebio Company Information
 Table 126. QiYuebio Description and Business Overview
 Table 127. QiYuebio Peptide-PNA (Peptide nucleic acid) Conjugate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 128. QiYuebio Peptide-PNA (Peptide nucleic acid) Conjugate Product
 Table 129. QiYuebio Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Peptide-PNA (Peptide nucleic acid) Conjugate Distributors List
 Table 133. Peptide-PNA (Peptide nucleic acid) Conjugate Customers List
 Table 134. Peptide-PNA (Peptide nucleic acid) Conjugate Market Trends
 Table 135. Peptide-PNA (Peptide nucleic acid) Conjugate Market Drivers
 Table 136. Peptide-PNA (Peptide nucleic acid) Conjugate Market Challenges
 Table 137. Peptide-PNA (Peptide nucleic acid) Conjugate Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Peptide-PNA (Peptide nucleic acid) Conjugate
 Figure 2. Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Share by Type: 2023 & 2030
 Figure 4. Short Peptide-conjugation Product Picture
 Figure 5. Long Peptide-conjugation Product Picture
 Figure 6. Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Share by Application: 2023 & 2030
 Figure 8. Molecular Probes
 Figure 9. Gene Editing
 Figure 10. Drug delivey
 Figure 11. Other
 Figure 12. Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Peptide-PNA (Peptide nucleic acid) Conjugate Sales (2019-2030) & (Kg)
 Figure 15. Global Peptide-PNA (Peptide nucleic acid) Conjugate Average Price (US$/g) & (2019-2030)
 Figure 16. Peptide-PNA (Peptide nucleic acid) Conjugate Report Years Considered
 Figure 17. Peptide-PNA (Peptide nucleic acid) Conjugate Sales Share by Manufacturers in 2023
 Figure 18. Global Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Peptide-PNA (Peptide nucleic acid) Conjugate Players: Market Share by Revenue in Peptide-PNA (Peptide nucleic acid) Conjugate in 2023
 Figure 20. Peptide-PNA (Peptide nucleic acid) Conjugate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Peptide-PNA (Peptide nucleic acid) Conjugate Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Peptide-PNA (Peptide nucleic acid) Conjugate Sales Market Share by Country (2019-2030)
 Figure 23. North America Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Market Share by Country (2019-2030)
 Figure 24. United States Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Peptide-PNA (Peptide nucleic acid) Conjugate Sales Market Share by Country (2019-2030)
 Figure 27. Europe Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Peptide-PNA (Peptide nucleic acid) Conjugate Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Market Share by Region (2019-2030)
 Figure 35. China Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Peptide-PNA (Peptide nucleic acid) Conjugate Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Peptide-PNA (Peptide nucleic acid) Conjugate Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Peptide-PNA (Peptide nucleic acid) Conjugate Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Peptide-PNA (Peptide nucleic acid) Conjugate by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Peptide-PNA (Peptide nucleic acid) Conjugate by Type (2019-2030)
 Figure 54. Global Peptide-PNA (Peptide nucleic acid) Conjugate Price (US$/g) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Peptide-PNA (Peptide nucleic acid) Conjugate by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Peptide-PNA (Peptide nucleic acid) Conjugate by Application (2019-2030)
 Figure 57. Global Peptide-PNA (Peptide nucleic acid) Conjugate Price (US$/g) by Application (2019-2030)
 Figure 58. Peptide-PNA (Peptide nucleic acid) Conjugate Value Chain
 Figure 59. Peptide-PNA (Peptide nucleic acid) Conjugate Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String